Eyenovia Inc (NAS:EYEN)
$ 0.5078 -0.0103 (-1.99%) Market Cap: 43.47 Mil Enterprise Value: 57.71 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 23/100

Q2 2021 Eyenovia Inc Earnings Call Transcript

Aug 11, 2021 / 08:30PM GMT
Release Date Price: $4.37 (+1.86%)
Operator

Thank you for standing by. This is the conference operator. Welcome to the Eyenovia Second Quarter 2021 Earnings Call. (Operator Instructions) The conference is being recorded. (Operator Instructions) I would like to now turn the conference over to Eric Ribner, Investor Relations. Go ahead, please.

Eric Ribner

Thank you. Thank you. Good afternoon, everyone, and welcome to Eyenovia's Second Quarter 2021 Earnings Conference Call and Audio Webcast. With me today are Eyenovia's Chief Operating Officer, Michael Rowe; and Eyenovia's Chief Financial Officer, John Gandolfo. Dr. Sean Ianchulev, Eyenovia's Chief Executive Officer and Chief Medical Officer, has an unavoidable conflict which arose and is not able to join today's call.

Earlier this afternoon, Eyenovia issued a press release announcing financial results for the 3 and 6 months period ended June 30, 2021. We encourage everyone to read today's press release as well as Eyenovia's quarterly report on Form 10-Q for the quarter ending June 30, 2021, which will be filed with the SEC. The company's press release

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot